Arcutis Biotherapeutics, Inc.

This study tests a medicated foam called ARQ-154 in 16 children aged 2 to 12 with psoriasis on their scalp and body. The goal is to see how much of the drug enters the blood and if it is safe. Participants apply the foam daily for several weeks, and doctors monitor side effects a…

This early-stage study tests a new drug called ARQ-234 for people with moderate to severe atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. The study includes healthy volunteers and people with eczema, who will receive either…